Kamyar Kalantar-Zadeh M.D. to Myocardial Infarction
This is a "connection" page, showing publications Kamyar Kalantar-Zadeh M.D. has written about Myocardial Infarction.
Connection Strength
1.132
-
Synergistic association of combined glycemic and blood pressure level with risk of complications in US veterans with diabetes. J Hypertens. 2016 May; 34(5):907-13.
Score: 0.488
-
To legitimize the contentious obesity paradox. Mayo Clin Proc. 2014 Aug; 89(8):1033-5.
Score: 0.432
-
Warfarin Use and Increased Mortality in End-Stage Renal Disease. Am J Nephrol. 2017; 46(4):249-256.
Score: 0.134
-
Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes: A Randomized Clinical Trial. JAMA. 2020 04 28; 323(16):1565-1573.
Score: 0.040
-
Effect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline characteristics of the BETonMACE trial. Am Heart J. 2019 11; 217:72-83.
Score: 0.038